Therapeutic Effects of Switching to Anagliptin from Other DPP-4 Inhibitors in T2DM Patients with Inadequate Glycemic Control: A Non-interventional, Single-Arm, Open-Label, Multicenter Observational Study

Kim, SY; Kim, S

Kim, S (通讯作者),Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Bucheon St Marys Hosp, 327 Sosa Ro, Bucheon 14647, South Korea.

DIABETES THERAPY, 2023; 14 (1): 109

Abstract

Introduction The effects of switching DPP-4 inhibitors in type 2 diabetes mellitus (T2DM) patients are being widely studied. However, information of w......

Full Text Link